Yuwen Gong

Lanzhou, 730030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Targeting EGFR with sanguinarine chloride: a novel approach to bladder cancer therapy.

Targeting EGFR with sanguinarine chloride: a novel approach to bladder cancer therapy.

Journal: Biochemical pharmacology
Published: July 17, 2025

TAK-901 targeted inhibition of EGFR activates transcription factor FOXO causing cell cycle arrest and apoptosis in bladder cancer.

TAK-901 targeted inhibition of EGFR activates transcription factor FOXO causing cell cycle arrest and apoptosis in bladder cancer.

Journal: Molecular cancer therapeutics
Published: May 07, 2025

TAK-901 Targeted Inhibition of EGFR Activates Transcription Factor FOXO, Causing Cell-cycle Arrest and Apoptosis in Bladder Cancer.

TAK-901 Targeted Inhibition of EGFR Activates Transcription Factor FOXO, Causing Cell-cycle Arrest and Apoptosis in Bladder Cancer.

Journal: Molecular cancer therapeutics
Published: May 07, 2025

Ro 31-8220 suppresses bladder cancer progression via enhancing autophagy in vitro and in vivo.

Ro 31-8220 suppresses bladder cancer progression via enhancing autophagy in vitro and in vivo.

Journal: FEBS open bio
Published: March 10, 2025

Comparative study on the efficacy of low-dose and full-dose BCG bladder perfusion therapy.

Comparative study on the efficacy of low-dose and full-dose BCG bladder perfusion therapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 27, 2024

Effect of smoking on the recurrence and progression of non-muscle-invasive bladder cancer.

Effect of smoking on the recurrence and progression of non-muscle-invasive bladder cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 08, 2024

Bladder Cancer Patients with Elevated SPRR1B Expression Experiencing a Poor Prognosis.

Bladder Cancer Patients with Elevated SPRR1B Expression Experiencing a Poor Prognosis.

Journal: Archivos espanoles de urologia
Published: July 10, 2024

FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening.

FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening.

Journal: Bioorganic chemistry
Published: June 24, 2024

SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway.

SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway.

Journal: Communications biology
Published: February 25, 2024

CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway.

CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway.

Journal: Free radical biology & medicine
Published: April 15, 2023

Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer.

Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer.

Journal: Molecular carcinogenesis
Published: November 24, 2021

Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA Pathway.

Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA Pathway.

Journal: Journal of oncology
Published: March 14, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026